Pomerantz Law Firm Has Filed a Class Action Against Ixia

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pomerantz Law Firm Has Filed a Class Action Against Ixia and Certain Officers -- XXIA

NEW YORK, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Ixia ("Ixia" or the "Company") (Nasdaq: XXIA ) and certain of its officers. The class action, filed in United States District Court, Central District of California, and docketed under 2:13-cv-8440, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired IXIA securities between April 29, 2010 and October 24, 2013 both dates inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

If you are a shareholder who purchased Ixia securities during the Class Period, you have until January 14, 2014 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com .   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Ixia delivers information technology solutions to a wide variety of organizations, through real-time monitoring, real-world testing, and rapid assessment of networks and systems. The Company's tools are purportedly used to provide "end-to-end visibility" and complete understanding into user behavior, security vulnerabilities, network capacity, application performance, and IT resiliency.

Throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company improperly recognized revenues related to its warranty and software maintenance contracts; (2) The Company's Chief Executive Officer "CEO" misstated his academic credentials and employment history; (3) the Company lacked adequate internal and financial controls; and (4) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.

On March 19, 2013, Ixia announced that it had filed a Form 12b-25 with the SEC relating to the Company's Annual Report on Form 10-K for the year ended December 31, 2012, and that the Company needed to delay the filing of its Annual Report, "to correct an error related to the manner in which [Ixia] recognizes revenues for its warranty and software maintenance contracts."

On April 3, 2013, Ixia announced that after a further evaluation of the Company's finances, and identifying an additional error in the Company's revenue recognition practices that required correction, the Company's management recommended to the audit committee of the Company that the Company restate previously issued financial statements for the fiscal years ended December 31, 2011 and 2010, and the fiscal quarters ended March 31, 2011, June 30, 2011, September 30, 2011, March 31, 2012, June 30, 2012, and September 30, 2012 (the, "Restated Periods"); and, that the financial statements from the Restated Periods should no longer be relied upon. On this news, the Company's shares declined $1.94 per share, or over 9.5%, to close on April 4, 2013, at $18.37 per share.

On October 24, 2013, the Company disclosed "Vic Alston has resigned as its President and CEO and as a member of its board of directors following a determination by the Ixia audit committee that although he had attended Stanford University, he had misstated his academic credentials, incorrectly claiming to have received a B.S. and a M.S. in Computer Science, and had misstated his age and early employment history." On this news, the Company's shares declined $0.78 per share, or nearly 5%, to close on October 25, 2013, at $14.94 per share.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz Grossman Hufford Dahlstrom & Gross LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 22

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 16

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 13

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 21

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Daily Fund Prices of WisdomTree Issuer

Updated Category News Views 111

Understanding the Daily Fund Prices In the dynamic world of investing, staying updated on daily fund prices is crucial. WisdomTree Issuer plc offers a diverse range of exchange-traded funds (ETFs) designed to cater to various investment strategies. These funds track different sectors, commodities, and asset classes, providing investors with numerous options. WisdomTree...

Continue Reading
Kelly Appoints Chris Layden as New CEO to Drive Growth

Updated Category News Views 260

Kelly Services Welcomes New Leadership Kelly Services, a leading global talent solutions provider, has announced the appointment of Chris Layden as its new president and chief executive officer, with effect from September 2. Layden succeeds Peter Quigley, who has announced his retirement after years of dedicated service. Quigley will still be part of Kelly as a strategic...

Continue Reading
Innovative Smart Socks Revolutionizing Foot Comfort Options

Updated Category News Views 99

Discover the Revolutionary Smart Massage Socks Innovation in comfort is constantly evolving, and the smart massage socks are at the forefront of this development. An inventor recognized a common problem faced by many: the need for relaxation and comfort in a portable format. This led to the creation of the CIRCULATION SOCKS, which aim to provide a soothing foot massage...

Continue Reading
Karmanos Cancer Institute Strengthens Team with New Expert

Updated Category News Views 115

New Addition to Karmanos Cancer Institute's Team José Larios, M.D., a specialized transplant hematologist, has recently joined the Barbara Ann Karmanos Cancer Institute. This institution is recognized for its comprehensive programs aimed at treating various hematologic conditions, including different types of blood cancers like leukemia and lymphoma. Expertise in Blood...

Continue Reading
Evive Brands Expands Horizons with Shine Acquisition

Updated Category News Views 174

Evive Brands Expands Horizons with Shine Acquisition Evive Brands, a prominent community of service-focused franchise companies, has made a significant move by acquiring Shine, a franchisor recognized for its extensive range of residential and commercial cleaning services. This acquisition not only enhances Evive's service portfolio but also aligns with its mission of...

Continue Reading